Advanced imaging technology detects undiagnosed metastases in high-risk prostate cancer

A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought.

Liver Concerns Foil GLP-1 Drug; Not Enough Menopause Training; Wegovy Supply Limits

Pfizer dropped development of lotiglipron, its investigational GLP-1 receptor agonist for obesity, due to elevated liver enzymes; could other agents in the drug class carry

August 16, 2023

Gabrielle Union-Wade promotes self-advocacy at media agency health event

Actor and producer Gabrielle Union-Wade often turns to social media for health advice. Her message to healthcare and pharma marketers? Do better. Union-Wade took the

April 16, 2024

Pharmalittle: We’re reading about AstraZeneca’s CEO pay, an ALS drug spat in the U.K., and more

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of phone

April 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.